Individuals 50 years of age or older continue to account for at least 10% of AIDS cases reported to the Centers for Disease Control and Prevention in recent years. Little research is devoted to addressing the specific issues affecting diagnosis, treatment, and prevention of AIDS in older Americans. Survival rates among elderly individuals infected with human immunodeficiency virus (HIV) are consistently decreased in comparison with those for younger patients. Elderly individuals also are less likely to use a condom during sexual intercourse or to participate in routine HIV testing. This article reviews the current literature concerning the changing epidemiology of AIDS among older Americans. The article also addresses AIDS-related morbidity and mortality, treatment issues, and HIV-prevention behaviors among the elderly. Enhanced clinician awareness of HIV in the elderly, along with further research concerning HIV treatment and prevention, is necessary to improve survival and outcome for those patients.
The epidemiology of HIV infection has markedly changed §50 years of age (6% of persons aged 50 -59 years, 28% of over the past decade. Despite changes in the demographics of persons aged 60 -69 years, and 64% of persons aged §70 years HIV-infected patients, two factors have remained constant: (1) had AIDS related to contaminated blood products) [1] . persons §50 years of age continue to constitute 10% of the In 1996 the CDC reported that persons §50 years of age adult AIDS population in the United States [1], and (2) survival accounted for 7,459 AIDS cases, or 11% of all AIDS cases is consistently shorter among patients with AIDS who are §50 involving patients aged §13 [2] . Of the patients aged §50 years of age [2 -10] . In addition to accounting for 10% of years reported in 1996, 48% were aged 50 -54 years, 26% were those with AIDS, patients §50 years are at particular risk for aged 55 -59 years, 14% were aged 60 -64 years, and 12% were morbidity and death because their AIDS is more likely to be aged §65 years. In contrast to the 15% of AIDS patients aged diagnosed later in the course of the disease. Elderly patients §50 years who, before 1989, reported receipt of blood products with AIDS have many unique issues regarding manifestation, as the mode of transmission, in 1996 only 2.4% of AIDS treatment, and prevention of HIV disease. This article reviews patients aged §50 years and 1.1% of those aged 13 -49 years recent literature concerning HIV with regard to epidemiology, reported receipt of blood or blood products as the mode of morbidity, mortality, treatment issues, social issues, and pretransmission [2] . Routine HIV screening of blood donations vention of infection for older Americans.
(beginning in 1985) and implementation of donor deferral has decreased the number and proportion of AIDS cases associated with contaminated blood products. However, despite the deEpidemiology crease in the proportion of AIDS patients infected through Before 1989, 10.4% (11,984) of the adults with AIDS who contaminated blood products, the proportion of reported AIDS were reported to the Centers for Disease Control and Prevention patients §50 years of age has not decreased. Instead, the per-(CDC) were §50 years of age. Seven percent of all reported centage of AIDS cases involving persons aged §50 years has adults with AIDS were aged 50 -59 years, 2.4% were aged remained stable at 11% since 1991 [1, 2]. 60 -69 years, and õ1% were aged §70 years [1]. Although While patients aged §50 years who were reported in 1996 contaminated blood products accounted for only 1% of cases were less likely to relate receipt of blood products than were among persons aged 13 -49 years, receipt of contaminated those of the same age group reported in 1989 (2.4% vs. 15%), blood products was the major risk factor for 15% of patients patients aged §50 years who were reported in 1996 were also less likely to have ''men who have sex with men'' (MSM) as the main mode of transmission than were those of the same age group reported before 1989 (36% vs. 60%). In contrast, pendent of the comorbidity variable [3] .) In addition to the effect of comorbidity in this population upon shortened survival, Skiest et al. hypothesized that the decreased survival of AIDS patients §55 years of age may be of cases among patients aged 13 -49 years. However, the secattributable to physiological mechanisms associated with aging, ond highest percentage of cases for patients aged §50 years such as the ''natural'' decline of the immune system (specifiwas associated with ''no reported risk'' (25.8%, vs. 15.6% for cally, T cell activity) that occurs with aging, higher viral load patients aged 13 -49). Injection-drug use was the third most after seroconversion, and increased drug intolerance among frequently reported risk factor (26%) for patients aged §50
patients aged §55 years. Finally, they hypothesized that proyears, but a significantly lower proportion of persons aged 13 -vider-related effects, such as decreased use of antiretroviral 49 years reported injection-drug use (19%). Finally, a higher agents in elderly patients and the lack of recognition of HIV/ percentage of patients aged §50 years (14.5%) than of those AIDS in this population by health care providers, resulted in aged 13 -49 years (12.7%) reported heterosexual contact as the late diagnosis and treatment of infection and poor outcome [3] . mode of exposure to the virus. In summary, in 1996 AIDS While few definitive data illuminate the role of decreased patients §50 years of age were more likely than those aged immune function in poor survival of patients §55 years of age 13 -49 years to be reported to the CDC with either ''no risk [17 -20] the diagnosis of HIV infection than were the younger patients in the control cohort [4] . As shown in the next section, HIV patients aged õ45 years, showed that an age of §55 years was predictive of a decreased AIDS-free interval and decreased infection is commonly diagnosed in the elderly after significant workup and treatment of other diseases have failed, delaying survival from time of HIV diagnosis [3] . Multiple other studies have shown similar findings. Ferro and Salit studied AIDSthe diagnosis of HIV infection from months to years. In some cases, the diagnosis of HIV is made only after the postmortem free survival among HIV-infected patients of age §50 years [4] The difficulties in diagnosing HIV infection become particularly challenging in patients §50 years of age because of the was significantly predictive of survival among patients who were infected with HIV through blood transfusion [7, 8] .
medical problems that are common in the elderly and easily confound the diagnosis. occurred in older patients [30] . Dermatologic manifestations are common presenting symptoms of HIV infection in older Several studies have shown that there is no significant difference in the prevalence of AIDS-defining opportunistic infecindividuals. Newcomber described four elderly HIV-positive patients, each presenting with one of the following dermatotions between older and younger patients infected with HIV, and all concur that Pneumocystis carinii pneumonia (PCP) is logic symptoms: seborrheic dermatitis, tubercular infection of the forehead, lymphoblastic lymphoma, and herpes simplex the most common opportunistic infection in older patients. Ferro et al. reported with regard to their sample of 33 that virus infection of the buttocks [31] . New-onset dementia is a frequent presenting and often diag-PCP, Kaposi's sarcoma, and HIV encephalopathy were the most common AIDS-defining conditions for both older and nostically difficult manifestation of HIV infection in older patients. Neurological complications in older AIDS patients preyounger patients [4] . Skiest et al. also found that PCP was one of the most common opportunistic infections in older and sent a specific problem because Alzheimer's disease is prevalent in this population. Weiler et al. reported a case of an younger AIDS patients and also reported that esophageal candidiasis and disseminated Mycobacterium avium complex infecelderly patient presenting with progressive dementia who was initially treated for Alzheimer's disease [24]. Mirra described tion were other common opportunistic infections [3] . More recently, Gaeta et al. reported from the 1993 CDC surveillance the case of a 57-year-old man for whom the presumptive diagnosis was Alzheimer's disease, but on neuropathological examdata that among patients §50 years of age, the most common opportunistic infections (in order of frequency) are PCP, wastination after his death, no neurofibrillary tangles or neuritic plaques were noted. It was later discovered that this person ing syndrome, candida esophagitis, and Kaposi's sarcoma [11] . Finally, the 1996 CDC surveillance report on persons with was in a high-risk group for HIV infection [21] . Several papers delineate the clinical differences between the AIDS aged §50 years also corroborates these findings, adding that older individuals were significantly more likely to develop dementia produced by Alzheimer's disease and the dementia of HIV infection [16, 22, 24, 25, 32] . The authors report four major wasting syndrome and HIV encephalopathy than were patients aged 13 -49 years [2].
differences. First, HIV is associated with subacute encephalitis, which eventually leads to a subcortical dementia and not cortical Despite the similar prevalence of opportunistic infections between AIDS patients aged 13 -49 years and those aged §50 dementia. Although AIDS dementia and Alzheimer's disease are both characterized by decreased attention and concentration, apayears, older patients often have poorer outcomes related to the AIDS-associated opportunistic infections. Wallace et al.
thy, social withdrawal, and psychomotor retardation, Alzheimer's disease is more likely to be associated with aphasia and other reported that elderly AIDS patients are uniquely at risk for higher morbidity due to opportunistic infections such as PCP manifestations of cortical dysfunction than is AIDS dementia. Second, HIV-related dementia progresses more rapidly and may (because in elderly patients lung disease progresses rapidly); tuberculosis (because many older individuals have been exbecome evident over months, as opposed to Alzheimer's disease, which usually progresses more slowly. The progression of HIVposed to it early in life and are more likely to develop disseminated infection); and herpes zoster (because of disseminated related dementia is also more often associated with peripheral neuropathies, myelopathies, and general physical complaints, infection, acyclovir resistance, and prolonged time to healing) [25] . Therefore, older AIDS patients are at higher risk for such as weight loss and fatigue. Third, HIV-related dementia may be associated with mildly late diagnosis of HIV infection as well as for morbidity from common opportunistic infections than are younger AIDS paelevated protein levels in the CSF, and Ç25% of patients will have mononuclear CSF pleocytosis. Alzheimer's disease is a tients.
In addition to AIDS-defining illnesses, there have been sevdiagnosis of exclusion and is not usually associated with CSF abnormalities. Finally, HIV-related cognitive abnormalities oferal case reports of HIV presenting ''atypically'' in older pa-/ 9c64$$ap58 03-19-99 05:10:03 cida UC: CID ten improve with antiretroviral therapy and thus may present diseases (STDs) in the elderly. In several studies, routine HIV testing in the elderly was shown to be uncommon [8, 34 -39] . as a reversible cause of dementia [24, 25] .
Schable et al. reported that elderly women with AIDS were more likely to be tested for HIV in the hospital than younger women and were significantly less likely to have been offered Treatment routine HIV testing [34]. Gordon et al. also reported in their study of older AIDS patients that 56% of elderly patients were To date, no studies have indicated that older AIDS patients should be treated differently for HIV disease. However, antirettested after the onset of AIDS-defining illnesses [12] . Stall and Catania showed, from the National AIDS Behavioral Surveys roviral treatment, prophylactic therapy, and treatment for opportunistic infections of older AIDS patients have not been data, that 96% of respondents §50 years of age in cities with low HIV prevalence reported never being tested for HIV, and extensively studied. Clinical drug trials often exclude older patients because of multiple medical problems or non-HIV-93% of respondents §50 years of age in cities with high HIV prevalence reported never being tested for HIV [35] . Finally, related medication regimens. In the United States, patients over 60 years of age were excluded from clinical trials until 1993.
Gerbert and Maguire found that fewer than 11% of persons over the age of 50 years reported that they had ever discussed Therefore, there are very few current data specifically concerning older patients and HIV medications. However, two studies AIDS with their physician [36] . In addition, HIV screening studies in large metropolitan hosand several anecdotal reports illustrate important ideas that could affect the treatment of older patients. In a study of 111 pitals show that HIV seropositivity exists among the elderly, but the diagnosis is commonly not recognized. Schoenbaum hemophiliacs, Phillips et al. noted that patients aged ú30 years were significantly more likely to develop AIDS-defining opporand Webber found HIV seropositivity in a small percentage of a random sample of patients aged §45 years seen in a New tunistic infections at consistently higher T-cell counts [6] . They concluded that it may be prudent to begin prophylactic treatYork City emergency department who were not previously known to be HIV-positive [37] . El Sadr and Gettler reported ments for AIDS at higher T-cell counts for these individuals. These data can be extrapolated to imply that such precautions that from a cohort of hospitalized patients §60 years of age who were not known to be HIV-positive, 5% of serum samples could also benefit patients aged §50 years.
In the second study, Sauvageon-Matre et al. found that there tested positive for HIV antibody [38] . While providers are often unaware of HIV in the elderly, was a significant decrease in the elimination of zidovudine in elderly patients. As a result, they reported that while taking the elderly themselves appear also to be unaware of the prevalence of HIV within their age group. It has been shown that recommended dosages, elderly patients commonly had toxic blood levels of zidovudine [33] . In addition to the findings of older Americans' sexual activity continues into the later years of life [40, 35] . Behavioral studies show that while the elderly previous studies, other drug toxicities, idiopathic drug reactions, and medical contraindications to antiretroviral therapy continue to engage in sexual activity, they are the least likely to practice HIV prevention [35 -39] . Schable et al. report that have all been reported anecdotally with regard to elderly patients [23]. Adler et al. hypothesized that elderly patients are in a cohort of women aged §50 years with AIDS, 86% reported that they had never used a condom within 5 years of knowing at increased risk for drug toxicity because of age-related losses of renal function, liver function, and albumin levels. In additheir HIV status. The investigators found this percentage to be statistically significantly greater than that of younger women tion, they speculate that patients with multiple medical problems who are taking many different classes of medications are [34] . Data from the National AIDS Behavioral Surveys confirm that condom use is infrequent among older Americans. Stall at high risk for unforeseen drug interactions and hypersensitivities [17] .
and Catania showed that older Americans were one-sixth as likely as Americans in their 20s to use condoms during vaginal Finally, very little literature and study has been devoted specifically to the role of protease inhibitors and aggressive or anal intercourse [35] . They also reported that of sexually active respondents aged 50 years or older, 82.9% in high-risk antiretroviral triple therapy in elderly patients. Few data have been published concerning the specific response of older AIDS cities and 92.4% in low-risk cities said they never use condoms. Catania et al. hypothesize that sexually active older individuals patients to new HIV antiretroviral treatments, and currently there are no guidelines for specific antiretroviral treatment moare at higher risk for HIV viral entry because of age-related mucosal disruption [41] . Therefore, it is particularly important dalities for patients §50 years of age.
for the elderly to practice condom use during sexual intercourse.
The prevention of other STDs besides HIV disease also Prevention needs to be addressed in the older population. Gordon and Thompson found that of 32 HIV-infected elderly patients, 10 HIV prevention in the elderly is difficult, often for the same reasons that HIV infection is diagnosed late in the elderly.
(31%) were known to be rapid plasma reagin -positive prior to their HIV infection diagnosis [12] . 
